- Info
- Significant Ownership
Significant Ownership of Sofinnova Crossover I
- Signature - Title
- /s/ Antoine Papiernik - Managing Partner
- Location
- Paris, France
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Sofinnova Crossover I.
Follow Filing Activity
Follow Sofinnova Crossover I and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Sofinnova Crossover I
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVA | Inventiva, S.A. | Ordinary Shares, nominal value EUR0.01 per share | 8.6% | $108,981,346 | +$64,487,273 | 19,086,050 | +145% | Sofinnova Partners SAS, a French corporation | 31 Dec 2025 |
| ABVX | Abivax S.A. | Ordinary Shares, par value EUR0.01 per share | 7.7% | $863,002,246 | -$269,710,200 | 6,399,478 | -24% | Sofinnova Crossover I SLP | 12 Jan 2026 |
Schedules 13D/G Reported by Sofinnova Crossover I:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.